Product Code: TIPRE00029916
The enteral and parenteral medical nutrition market size is expected to grow from US$ 17.34 billion in 2022 to US$ 25.47 billion by 2028; it is estimated to record a CAGR of 6.8% from 2023 to 2028.
The enteral and parenteral medical nutrition market growth is attributed to the rise in the prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.
There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Efforts of companies for offering such formulations for unique need will propel the growth of the enteral and parenteral medical nutrition market.
Additionally, various organizations are making efforts to spread awareness of the use of specific nutritional formulations. For instance, the American Society for Parenteral and Enteral Nutrition (called ASPEN) is a US-based medical professional organization that employs dietitians, pharmacists, physicians and assistants, nurses, nurse practitioners, scientists, students, and other health professionals from every field of nutrition to provide clinical nutrition to patients and educate them. Such factors will support the enteral and parenteral medical nutrition market growth in the future.
Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to propose plant-based meal options to improve patients' health. States including California, New York, and the District of Columbia have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral and parenteral medical nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Similarly, olive oil-based parenteral nutrition products are also gaining popularity.
Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral and parenteral medical nutrition market.
Age Group -Based Insights
Based on age group, the enteral and parenteral medical nutrition market is categorized into above 60 years, 18-60 years, 3-18 years, and below 3 years. In 2022, the above 60 years segment accounted for the largest share in enteral and parenteral medical nutrition market. However, the 18-60 years segment is anticipated to register the highest CAGR during the forecast period. Weight loss and malnutrition are common in people aged above 60 years. With increasing age, the immunity of the older population decreases, and they become more prone to diseases that may deteriorate their health. Due to this, doctors prescribe external nutrition to maintain immunity and weight. According to several studies published in PubMed Central, the prevalence of chronic diseases and disabilities is significantly higher among geriatric people, generating the need for home-based treatments. Also, as per the Population Reference Bureau (2019), it is estimated that the senior population of the US is expected to grow from 52 million in 2018 to 95 million by 2060. The need for home therapy has increased due to the growing demand for home care owing to disability among old age groups. Thus, the increasing geriatric population base is expected to promote the growth of segment in the enteral and parenteral medical nutrition market.
The British Association for Parenteral and Enteral Nutrition, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the enteral and parenteral medical nutrition market report.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the enteral and parenteral medical nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global enteral and parenteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Global Enteral and Parenteral Medical Nutrition Market - By Indication
- 1.3.2 Global Enteral and Parenteral Medical Nutrition Market - By Nutrition Type
- 1.3.3 Global Enteral and Parenteral Medical Nutrition Market - By Form
- 1.3.4 Global Enteral and Parenteral Medical Nutrition Market - By Product Type
- 1.3.5 Global Enteral and Parenteral Medical Nutrition Market - By Route of Administration
- 1.3.6 Global Enteral and Parenteral Medical Nutrition Market - By Age Group
- 1.3.7 Global Enteral and Parenteral Medical Nutrition Market - By Distribution Channel
- 1.3.8 Global Enteral and Parenteral Medical Nutrition Market - By Geography
2. Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Enteral and Parenteral Medical Nutrition Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East and Africa PEST Analysis
- 4.2.5 South And Central America PEST Analysis
- 4.3 Experts Opinion
- 4.4 Energy Content Analysis
- 4.4.1 Lower than 1.5 kcal/ml
- 4.4.2 Equals to 1.5 kcal/ml
- 4.4.3 Lower than 2kcal/ml:
- 4.4.4 Equal to or Higher than 2kcal/ml:
5. Enteral and Parenteral Medical Nutrition Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rise in Prevalence of Gastrointestinal Diseases
- 5.1.2 Increasing Cases of Malnutrition and Premature Births
- 5.2 Market Restraints
- 5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Enteral and Parenteral Feeding Systems, and Limitations Related to Catheter Placement
- 5.3 Market Opportunities
- 5.3.1 Growing Strategic Initiatives by Companies
- 5.4 Future Trends
- 5.4.1 Specific Formulations and Plant-Based Nutrition Products
- 5.5 Impact Analysis
6. Enteral and Parenteral Medical Nutrition Market - Global Analysis
- 6.1 Global Enteral and Parenteral Medical Nutrition Market Revenue Forecast and Analysis
- 6.1.1 Global Enteral and Parenteral Medical Nutrition Market, By Geography - Forecast and Analysis
- 6.2 Company Analysis
- 6.2.1 Market Positioning of Key Players
- 6.3 Market Share Analysis of Enteral and Parenteral Medical Nutrition Market
7. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Indication
- 7.1 Overview
- 7.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
- 7.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
- 7.3 Elderly
- 7.3.1 Overview
- 7.3.2 Elderly: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
- 7.4 Gastrointestinal Disorders
- 7.4.1 Overview
- 7.4.2 Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
- 7.4.3 Inflammatory Bowel Disease
- 7.4.3.1 Overview
- 7.4.3.2 IBD: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.3.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
- 7.4.4 Irritable Bowel Syndrome
- 7.4.4.1 Overview
- 7.4.4.2 IBS: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.4.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
- 7.4.6 Others
- 7.4.6.1 Overview
- 7.4.6.2 Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.6.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
- 7.5 Diabetes
- 7.5.1 Overview
- 7.5.2 Diabetes: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.2.1.1 Global: Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
- 7.6 Cancer
- 7.6.1 Overview
- 7.6.2 Cancer: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
- 7.7 Respiratory Disorders
- 7.7.1 Overview
- 7.7.2 Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.7.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form, 2020-2028 (US$ Million)
- 7.8 Alzheimer's Disease
- 7.8.1 Overview
- 7.8.2 Alzheimer's Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
- 7.9 Dementia
- 7.9.1 Overview
- 7.9.2 Dementia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.9.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
- 7.10 Renal Disease
- 7.10.1 Overview
- 7.10.2 Renal Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.10.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
- 7.11 Liver Failure
- 7.11.1 Overview
- 7.11.2 Liver Failure: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.11.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
- 7.12 Post COVID-19
- 7.12.1 Overview
- 7.12.2 Post COVID-19: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.12.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
- 7.13 Other Indications
- 7.13.1 Overview
- 7.13.2 Other Indications: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 7.13.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
8. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Nutrition Type
- 8.1 Overview
- 8.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
- 8.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
- 8.3 Supplemental
- 8.3.1 Overview
- 8.3.2 Supplemental: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Sole-Source
- 8.4.1 Overview
- 8.4.2 Sole-Source: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
9. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Form
- 9.1 Overview
- 9.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
- 9.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
- 9.3 Liquid
- 9.3.1 Overview
- 9.3.2 Liquid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Powder
- 9.4.1 Overview
- 9.4.2 Powder: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Semi-Solid
- 9.5.1 Overview
- 9.5.2 Semi-Solid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
10. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Product Type
- 10.1 Overview
- 10.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
- 10.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
- 10.3 General
- 10.3.1 Overview
- 10.3.2 General: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 10.4 Disease-Specific
- 10.4.1 Overview
- 10.4.2 Disease-Specific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
11. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Route of Administration
- 11.1 Overview
- 11.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
- 11.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
- 11.3 Oral
- 11.3.1 Overview
- 11.3.2 Oral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 11.4 Tube Feed
- 11.4.1 Overview
- 11.4.2 Tube Feed: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 11.5 Parenteral
- 11.5.1 Overview
- 11.5.2 Parenteral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
12. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Age Group
- 12.1 Overview
- 12.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
- 12.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
- 12.3 Above 60 Years
- 12.3.1 Overview
- 12.3.2 Above 60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 12.4 18-60 Years
- 12.4.1 Overview
- 12.4.2 18-60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 12.5 3-18 Years
- 12.5.1 Overview
- 12.5.2 3-18 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 12.6 Below 3 Years
- 12.6.1 Overview
- 12.6.2 Below 3 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
13. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Distribution Channel
- 13.1 Overview
- 13.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
- 13.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
- 13.3 Hospital Pharmacies
- 13.3.1 Overview
- 13.3.2 Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 13.4 Retail Stores
- 13.4.1 Overview
- 13.4.2 Retail Stores: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 13.5 E-Commerce
- 13.5.1 Overview
- 13.5.2 E-Commerce: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 13.6 Others
- 13.6.1 Overview
- 13.6.2 Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
14. Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - Geographic Analysis
- 14.1 North America: Enteral and Parenteral Medical Nutrition Market
- 14.1.9.1 US: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 14.1.9.2 Canada: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 14.2 Europe: Enteral and Parenteral Medical Nutrition Market
- 14.2.1 Overview
- 14.2.10.1 Germany: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.2 UK: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.3 France: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.4 Italy: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.5 Spain: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.6 Netherlands: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.7 Switzerland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.8 Poland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.9 Sweden: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.10 Belgium: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.2.10.11 Rest of Europe: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3 Asia Pacific: Enteral and Parenteral Medical Nutrition Market
- 14.3.1 Overview
- 14.3.9.1 China: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3.9.1.1 Overview
- 14.3.9.2 Japan: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3.9.3 India: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3.9.4 Australia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3.9.5 South Korea: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3.9.6 Indonesia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3.9.7 Thailand: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3.9.8 Vietnam: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.3.9.9 Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.4 Middle East & Africa Enteral and Parenteral Medical Nutrition Market
- 14.4.1 Overview
- 14.4.9.1 Saudi Arabia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.4.9.2 South Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.4.9.3 UAE: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.4.9.4 Iran: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.4.9.5 Israel: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.4.9.6 Egypt: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.4.9.7 Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.5 South & Central America Enteral and Parenteral Medical Nutrition Market
- 14.5.1 Overview
- 14.5.10.1 Mexico: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.5.10.2 Brazil: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.5.10.3 Argentina: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.5.10.4 Chile: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.5.10.5 Peru: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.5.10.6 Colombia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
- 14.5.10.7 Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
15. Impact Of COVID-19 Pandemic on Enteral and Parenteral Medical Nutrition Market
- 15.1 North America: Impact Assessment of COVID-19 Pandemic
- 15.2 Europe: Impact Assessment of COVID-19 Pandemic
- 15.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
- 15.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
- 15.5 South & Central America: Impact Assessment of COVID-19 Pandemic
16. Enteral and Parenteral Medical Nutrition Market – Industry Landscape
- 16.1 Overview
- 16.2 Growth Strategies in the Enteral and Parenteral Medical Nutrition Market
- 16.3 Inorganic Growth Strategies
- 16.3.1 Overview
- 16.4 Organic Growth Strategies
- 16.4.1 Overview
17. Company Profiles
- 17.1 Abbott Laboratories
- 17.1.1 Key Facts
- 17.1.2 Business Description
- 17.1.3 Products and Services
- 17.1.4 Financial Overview
- 17.1.5 SWOT Analysis
- 17.1.6 Key Developments
- 17.2 Nestle SA
- 17.2.1 Key Facts
- 17.2.2 Business Description
- 17.2.3 Products and Services
- 17.2.4 Financial Overview
- 17.2.5 SWOT Analysis
- 17.2.6 Key Developments
- 17.3 Nutricia International BV
- 17.3.1 Key Facts
- 17.3.2 Business Description
- 17.3.3 Products and Services
- 17.3.4 Financial Overview
- 17.3.5 SWOT Analysis
- 17.3.6 Key Developments
- 17.4 Medtrition Inc
- 17.4.1 Key Facts
- 17.4.2 Business Description
- 17.4.3 Products and Services
- 17.4.4 Financial Overview
- 17.4.5 SWOT Analysis
- 17.4.6 Key Developments
- 17.5 Fresenius Kabi AG
- 17.5.1 Key Facts
- 17.5.2 Business Description
- 17.5.3 Products and Services
- 17.5.4 Financial Overview
- 17.5.5 SWOT Analysis
- 17.5.6 Key Developments
- 17.6 B. Braun SE
- 17.6.1 Key Facts
- 17.6.2 Business Description
- 17.6.3 Products and Services
- 17.6.4 Financial Overview
- 17.6.5 SWOT Analysis
- 17.6.6 Key Developments
- 17.7 Smartfish AS
- 17.7.1 Key Facts
- 17.7.2 Business Description
- 17.7.3 Products and Services
- 17.7.4 Financial Overview
- 17.7.5 SWOT Analysis
- 17.7.6 Key Developments
- 17.8 Nutrisens SAS
- 17.8.1 Key Facts
- 17.8.2 Business Description
- 17.8.3 Products and Services
- 17.8.4 Financial Overview
- 17.8.5 SWOT Analysis
- 17.8.6 Key Developments
- 17.9 AYMES International Ltd
- 17.9.1 Key Facts
- 17.9.2 Business Description
- 17.9.3 Products and Services
- 17.9.4 Financial Overview
- 17.9.5 SWOT Analysis
- 17.9.6 Key Developments
- 17.10 Medifood International SA
- 17.10.1 Key Facts
- 17.10.2 Business Description
- 17.10.3 Products and Services
- 17.10.4 Financial Overview
- 17.10.5 SWOT Analysis
- 17.10.6 Key Developments
- 17.11 Easy Line Ltd
- 17.11.1 Key Facts
- 17.11.2 Business Description
- 17.11.3 Products and Services
- 17.11.4 Financial Overview
- 17.11.5 SWOT Analysis
- 17.11.6 Key Developments
- 17.12 Charing Cross Scientific AS
- 17.12.1 Key Facts
- 17.12.2 Business Description
- 17.12.3 Products and Services
- 17.12.4 Financial Overview
- 17.12.5 SWOT Analysis
- 17.12.6 Key Developments
- 17.13 Baxter International Inc
- 17.13.1 Key Facts
- 17.13.2 Business Description
- 17.13.3 Products and Services
- 17.13.4 Financial Overview
- 17.13.5 SWOT Analysis
- 17.13.6 Key Developments
- 17.14 Medica Nutrition Inc
- 17.14.1 Key Facts
- 17.14.2 Business Description
- 17.14.3 Products and Services
- 17.14.4 Financial Overview
- 17.14.5 SWOT Analysis
- 17.14.6 Key Developments
18. Appendix
- 18.1 About The Insight Partners
- 18.2 Glossary of Terms